[4-chloro-3-[[4-(1,1-difluoroethyl)phenyl]methyl]-2-methoxyquinolin-6-yl]-(1-methylazetidin-3-yl)-(3-methyltriazol-4-yl)methanol;[4-chloro-3-[[4-(1,1-difluoroethyl)phenyl]methyl]-2-methoxyquinolin-6-yl]-(3-methylimidazol-4-yl)-(3-methyltriazol-4-yl)methanol;[2,4-dichloro-3-[(4-methylsulfanylphenyl)methyl]quinolin-6-yl]-(2,6-dimethyl-3-pyridinyl)-(3-methyltriazol-4-yl)methanol;3-[[4-(1,1-difluoroethyl)phenyl]methyl]-6-[(3,5-dimethyl-1,2-oxazol-4-yl)-hydroxy-(3-methyltriazol-4-yl)methyl]-2-methoxyquinoline-4-carbonitrile
C111H104Cl4F6N22O8S — CID 161041988
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4-chloro-3-[[4-(1,1-difluoroethyl)phenyl]methyl]-2-methoxyquinolin-6-yl]-(1-methylazetidin-3-yl)-(3-methyltriazol-4-yl)methanol;[4-chloro-3-[[4-(1,1-difluoroethyl)phenyl]methyl]-2-methoxyquinolin-6-yl]-(3-methylimidazol-4-yl)-(3-methyltriazol-4-yl)methanol;[2,4-dichloro-3-[(4-methylsulfanylphenyl)methyl]quinolin-6-yl]-(2,6-dimethyl-3-pyridinyl)-(3-methyltriazol-4-yl)methanol;3-[[4-(1,1-difluoroethyl)phenyl]methyl]-6-[(3,5-dimethyl-1,2-oxazol-4-yl)-hydroxy-(3-methyltriazol-4-yl)methyl]-2-methoxyquinoline-4-carbonitrile
[4-chloro-3-[[4-(1,1-difluoroethyl)phenyl]methyl]-2-methoxyquinolin-6-yl]-(1-methylazetidin-3-yl)-(3-methyltriazol-4-yl)methanol;[4-chloro-3-[[4-(1,1-difluoroethyl)phenyl]methyl]-2-methoxyquinolin-6-yl]-(3-methylimidazol-4-yl)-(3-methyltriazol-4-yl)methanol;[2,4-dichloro-3-[(4-methylsulfanylphenyl)methyl]quinolin-6-yl]-(2,6-dimethyl-3-pyridinyl)-(3-methyltriazol-4-yl)methanol;3-[[4-(1,1-difluoroethyl)phenyl]methyl]-6-[(3,5-dimethyl-1,2-oxazol-4-yl)-hydroxy-(3-methyltriazol-4-yl)methyl]-2-methoxyquinoline-4-carbonitrile (PubChem CID 161041988) has the molecular formula C111H104Cl4F6N22O8S and a molecular weight of 2162.07 g/mol. Its IUPAC name is [4-chloro-3-[[4-(1,1-difluoroethyl)phenyl]methyl]-2-methoxyquinolin-6-yl]-(1-methylazetidin-3-yl)-(3-methyltriazol-4-yl)methanol;[4-chloro-3-[[4-(1,1-difluoroethyl)phenyl]methyl]-2-methoxyquinolin-6-yl]-(3-methylimidazol-4-yl)-(3-methyltriazol-4-yl)methanol;[2,4-dichloro-3-[(4-methylsulfanylphenyl)methyl]quinolin-6-yl]-(2,6-dimethyl-3-pyridinyl)-(3-methyltriazol-4-yl)methanol;3-[[4-(1,1-difluoroethyl)phenyl]methyl]-6-[(3,5-dimethyl-1,2-oxazol-4-yl)-hydroxy-(3-methyltriazol-4-yl)methyl]-2-methoxyquinoline-4-carbonitrile.
Molecular Properties
| Compound Name | [4-chloro-3-[[4-(1,1-difluoroethyl)phenyl]methyl]-2-methoxyquinolin-6-yl]-(1-methylazetidin-3-yl)-(3-methyltriazol-4-yl)methanol;[4-chloro-3-[[4-(1,1-difluoroethyl)phenyl]methyl]-2-methoxyquinolin-6-yl]-(3-methylimidazol-4-yl)-(3-methyltriazol-4-yl)methanol;[2,4-dichloro-3-[(4-methylsulfanylphenyl)methyl]quinolin-6-yl]-(2,6-dimethyl-3-pyridinyl)-(3-methyltriazol-4-yl)methanol;3-[[4-(1,1-difluoroethyl)phenyl]methyl]-6-[(3,5-dimethyl-1,2-oxazol-4-yl)-hydroxy-(3-methyltriazol-4-yl)methyl]-2-methoxyquinoline-4-carbonitrile |
|---|---|
| PubChem CID | 161041988 |
| Molecular Formula | C111H104Cl4F6N22O8S |
| Molecular Weight | 2162.07 g/mol |
| Exact Mass | 2158.68 |
| IUPAC Name | [4-chloro-3-[[4-(1,1-difluoroethyl)phenyl]methyl]-2-methoxyquinolin-6-yl]-(1-methylazetidin-3-yl)-(3-methyltriazol-4-yl)methanol;[4-chloro-3-[[4-(1,1-difluoroethyl)phenyl]methyl]-2-methoxyquinolin-6-yl]-(3-methylimidazol-4-yl)-(3-methyltriazol-4-yl)methanol;[2,4-dichloro-3-[(4-methylsulfanylphenyl)methyl]quinolin-6-yl]-(2,6-dimethyl-3-pyridinyl)-(3-methyltriazol-4-yl)methanol;3-[[4-(1,1-difluoroethyl)phenyl]methyl]-6-[(3,5-dimethyl-1,2-oxazol-4-yl)-hydroxy-(3-methyltriazol-4-yl)methyl]-2-methoxyquinoline-4-carbonitrile |
| SMILES | COc1nc2ccc(C(O)(c3c(C)noc3C)c3cnnn3C)cc2c(C#N)c1Cc1ccc(C(C)(F)F)cc1.COc1nc2ccc(C(O)(c3cncn3C)c3cnnn3C)cc2c(Cl)c1Cc1ccc(C(C)(F)F)cc1.COc1nc2ccc(C(O)(c3cnnn3C)C3CN(C)C3)cc2c(Cl)c1Cc1ccc(C(C)(F)F)cc1.CSc1ccc(Cc2c(Cl)nc3ccc(C(O)(c4ccc(C)nc4C)c4cnnn4C)cc3c2Cl)cc1 |
| InChI | InChI=1S/C29H26F2N6O3.C28H25Cl2N5OS.C27H25ClF2N6O2.C27H28ClF2N5O2/c1-16-26(17(2)40-35-16)29(38,25-15-33-36-37(25)4)20-10-11-24-21(13-20)23(14-32)22(27(34-24)39-5)12-18-6-8-19(9-7-18)28(3,30)31;1-16-5-11-23(17(2)32-16)28(36,25-15-31-34-35(25)3)19-8-12-24-21(14-19)26(29)22(27(30)33-24)13-18-6-9-20(37-4)10-7-18;1-26(29,30)17-7-5-16(6-8-17)11-20-24(28)19-12-18(9-10-21(19)33-25(20)38-4)27(37,22-13-31-15-35(22)2)23-14-32-34-36(23)3;1-26(29,30)17-7-5-16(6-8-17)11-21-24(28)20-12-18(9-10-22(20)32-25(21)37-4)27(36,19-14-34(2)15-19)23-13-31-33-35(23)3/h6-11,13,15,38H,12H2,1-5H3;5-12,14-15,36H,13H2,1-4H3;5-10,12-15,37H,11H2,1-4H3;5-10,12-13,19,36H,11,14-15H2,1-4H3 |
| InChIKey | UAZQRIMJTSWPPV-UHFFFAOYSA-N |
| XLogP | 20.38 |
| TPSA | 366.78 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 31 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 152 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2162.07 |
| LogP ≤ 5 | 20.38 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 31 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161041988 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.